Clinical Trial Update: Study of the Prevalence of Endogenous Hypercortisolism in Patients With Resistant Hypertension (MOMENTUM)

View source ↗

Summary

This completed clinical trial from Corcept Therapeutics investigated the prevalence of endogenous hypercortisolism in patients with resistant hypertension (MOME…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercortisolism
• Resistant Hypertension

Drugs mentioned

• Korlym (mifepristone)

Snippet

Sponsor: Corcept Therapeutics | Conditions: Resistant Hypertension, Hypercortisolism | Status: COMPLETED